Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1

Author:  ["Kyoko Tsukiyama-Kohara","Francis Poulin","Michinori Kohara","Christine T. DeMaria","Alan Cheng","Zhidan Wu","Anne-Claude Gingras","Asao Katsume","Mounib Elchebly","Bruce M. Spiegelman","Mary-Ellen Harper","Michel L. Tremblay","Nahum Sonenberg"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

All nuclear-encoded mRNAs contain a 5′ cap structure (m7GpppN, where N is any nucleotide), which is recognized by the eukaryotic translation initiation factor 4E (eIF4E) subunit of the eIF4F complex. The eIF4E-binding proteins constitute a family of three polypeptides that reversibly repress cap-dependent translation by binding to eIF4E, thus preventing the formation of the eIF4F complex. We investigated the biological function of 4E-BP1 by disrupting its gene (Eif4ebp1) in the mouse. Eif4ebp1−/− mice manifest markedly smaller white fat pads than wild-type animals, and knockout males display an increase in metabolic rate. The males' white adipose tissue contains cells that exhibit the distinctive multilocular appearance of brown adipocytes, and expresses the uncoupling protein 1 (UCP1), a specific marker of brown fat. Consistent with these observations, translation of the peroxisome proliferator-activated receptor-γ co-activator 1 (PGC1), a transcriptional co-activator implicated in mitochondrial biogenesis and adaptive thermogenesis, is increased in white adipose tissue of Eif4ebp1−/− mice. These findings demonstrate that 4E-BP1 is a novel regulator of adipogenesis and metabolism in mammals.

Cite this article

Tsukiyama-Kohara, K., Poulin, F., Kohara, M. et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 7, 1128–1132 (2001). https://doi.org/10.1038/nm1001-1128

View full text

>> Full Text:   Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1

Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling

Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resis